168.85
price down icon4.70%   -8.33
after-market After Hours: 169.90 1.05 +0.62%
loading
Iqvia Holdings Inc stock is traded at $168.85, with a volume of 7.06M. It is down -4.70% in the last 24 hours and down -29.90% over the past month. Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$177.18
Open:
$162.93
24h Volume:
7.06M
Relative Volume:
4.32
Market Cap:
$28.64B
Revenue:
$15.90B
Net Income/Loss:
$1.28B
P/E Ratio:
23.18
EPS:
7.2842
Net Cash Flow:
$2.21B
1W Performance:
-6.69%
1M Performance:
-29.90%
6M Performance:
-9.18%
1Y Performance:
-14.64%
1-Day Range:
Value
$156.66
$170.00
1-Week Range:
Value
$156.66
$194.83
52-Week Range:
Value
$134.65
$247.04

Iqvia Holdings Inc Stock (IQV) Company Profile

Name
Name
Iqvia Holdings Inc
Name
Phone
919-998-2000
Name
Address
2400 ELLIS ROAD, DURHAM, NC
Name
Employee
91,000
Name
Twitter
@IQVIA_global
Name
Next Earnings Date
2025-07-22
Name
Latest SEC Filings
Name
IQV's Discussions on Twitter

Compare IQV vs TMO, DHR, IDXX, A, WAT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
168.85 30.05B 15.90B 1.28B 2.21B 7.2842
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
509.82 198.06B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
214.94 155.50B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
617.20 51.80B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
124.88 36.46B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
319.83 32.29B 3.17B 642.63M 539.81M 10.77

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-25 Resumed Morgan Stanley Overweight
Nov-13-25 Initiated BMO Capital Markets Outperform
Nov-03-25 Downgrade TD Cowen Buy → Hold
Oct-29-25 Upgrade Robert W. Baird Neutral → Outperform
Oct-09-25 Upgrade HSBC Securities Hold → Buy
Sep-09-25 Upgrade Jefferies Hold → Buy
Apr-25-25 Downgrade HSBC Securities Buy → Hold
Apr-10-25 Downgrade Barclays Overweight → Equal Weight
Feb-03-25 Downgrade BTIG Research Buy → Neutral
Dec-20-24 Initiated Stephens Overweight
Oct-14-24 Initiated Redburn Atlantic Buy
Sep-04-24 Initiated RBC Capital Mkts Outperform
Jul-24-24 Downgrade Jefferies Buy → Hold
Jun-06-24 Initiated Goldman Buy
Feb-26-24 Initiated Leerink Partners Outperform
Feb-15-24 Downgrade Guggenheim Buy → Neutral
Feb-13-24 Initiated BTIG Research Buy
Nov-02-23 Downgrade Robert W. Baird Outperform → Neutral
Sep-06-23 Initiated HSBC Securities Buy
Mar-17-23 Initiated Truist Buy
Dec-06-22 Initiated Cowen Outperform
Nov-17-22 Downgrade Citigroup Buy → Neutral
Aug-25-22 Initiated Credit Suisse Outperform
Jul-15-22 Initiated SVB Leerink Outperform
May-24-22 Initiated Guggenheim Buy
Apr-29-22 Upgrade Piper Sandler Neutral → Overweight
Apr-25-22 Downgrade Wells Fargo Overweight → Equal Weight
Aug-05-21 Resumed Credit Suisse Outperform
Apr-16-21 Upgrade Stephens Equal-Weight → Overweight
Mar-08-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21 Initiated Barclays Overweight
Jul-07-20 Initiated Stephens Equal-Weight
Mar-02-20 Initiated Deutsche Bank Buy
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Dec-13-19 Upgrade CFRA Sell → Hold
Nov-14-19 Upgrade Wolfe Research Peer Perform → Outperform
Jun-21-19 Upgrade Mizuho Neutral → Buy
May-28-19 Initiated SVB Leerink Outperform
Jan-18-19 Upgrade Jefferies Hold → Buy
Oct-09-18 Initiated UBS Buy
Oct-02-18 Reiterated Robert W. Baird Outperform
Jul-25-18 Upgrade BofA/Merrill Neutral → Buy
Jul-25-18 Reiterated Stifel Buy
Jul-03-18 Upgrade Raymond James Outperform → Strong Buy
Apr-13-18 Upgrade Goldman Neutral → Buy
Mar-07-18 Upgrade SunTrust Hold → Buy
Jan-19-18 Initiated Evercore ISI Outperform
View All

Iqvia Holdings Inc Stock (IQV) Latest News

pulisher
11:14 AM

The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call - Finviz

11:14 AM
pulisher
06:00 AM

Earnings growth of 3.6% over 3 years hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders - Yahoo Finance

06:00 AM
pulisher
05:31 AM

75,170 Shares in IQVIA Holdings Inc. $IQV Purchased by Eubel Brady & Suttman Asset Management Inc. - MarketBeat

05:31 AM
pulisher
Feb 10, 2026

IQVIA Holdings Inc (IQV) Shares Gap Down to $186.065 on Feb 10 - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Global obesity trials get boost from new IQVIA–Duke research pact - Stock Titan

Feb 10, 2026
pulisher
Feb 10, 2026

Compagnie Lombard Odier SCmA Cuts Stake in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Aug EndMonth: Is IQVIA Holdings Inc stock influenced by commodity pricesTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 09, 2026

IQVIA revenue for Q4 2025 up 10.3% to USD 4,364M - Medical Buyer

Feb 09, 2026
pulisher
Feb 09, 2026

Candriam S.C.A. Grows Position in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day - Longbridge

Feb 09, 2026
pulisher
Feb 08, 2026

IQVIA Expands AI Data Partnerships As Investors Weigh Growth Prospects - Yahoo Finance

Feb 08, 2026
pulisher
Feb 08, 2026

Rally Mode: Is Vipshop Holdings Limited Depositary Receipt subject to activist investor interestQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 08, 2026

IQVIA Holdings (IQV) Valuation Check After Profit Guidance Disappoints Despite Solid Quarterly Revenue Beat - Sahm

Feb 08, 2026
pulisher
Feb 07, 2026

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail

Feb 07, 2026
pulisher
Feb 07, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail

Feb 07, 2026
pulisher
Feb 07, 2026

Thrivent Financial for Lutherans Has $5.76 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

Envestnet Asset Management Inc. Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

IQVIA Fell 19% This Week. Could Shares Push Toward $260 in 2026? - TIKR.com

Feb 07, 2026
pulisher
Feb 06, 2026

Jefferies lowers IQVIA stock price target to $255 on margin pressures By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 06, 2026

IQVIA Leans On AI And Boehringer Deal As Shares Struggle - Sahm

Feb 06, 2026
pulisher
Feb 06, 2026

IQVIA Q4 Earnings Call Highlights - Yahoo Finance

Feb 06, 2026
pulisher
Feb 06, 2026

Jefferies lowers IQVIA stock price target to $255 on margin pressures - Investing.com UK

Feb 06, 2026
pulisher
Feb 06, 2026

IQV: JP Morgan Lowers Price Target While Maintaining Overweight Rating | IQV Stock News - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns By Investing.com - Investing.com Australia

Feb 06, 2026
pulisher
Feb 06, 2026

UBS Adjusts IQVIA Holdings (IQV) Price Target to $240 Amidst Ste - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Jefferies Lowers Price Target for IQVIA Holdings (IQV) to $255 | - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

IQV Analyst Rating Update: Stifel Lowers Price Target to $220 | IQV Stock News - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Barclays Analyst Lowers Price Target for IQV to $210 | IQV Stock News - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance

Feb 06, 2026
pulisher
Feb 06, 2026

Leerink Partners Adjusts Price Target on IQVIA Holdings to $228 From $256, Maintains Outperform Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Evercore ISI Adjusts Price Target on IQVIA Holdings to $225 From $250, Maintains Outperform Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Barclays Adjusts IQVIA Price Target to $210 From $230, Maintains Equal Weight Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

JPMorgan Adjusts IQVIA Price Target to $225 From $255, Maintains Overweight Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Citigroup Adjusts IQVIA Price Target to $200 From $230, Maintains Neutral Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis - Finviz

Feb 06, 2026
pulisher
Feb 06, 2026

TD Waterhouse Canada Inc. Sells 16,903 Shares of IQVIA Holdings Inc. $IQV - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

IQVIA Holdings Inc. (NYSE:IQV) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 06, 2026
pulisher
Feb 06, 2026

Jefferies Adjusts Price Target on IQVIA Holdings to $255 From $270, Maintains Buy Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Stifel Adjusts Price Target on IQVIA Holdings to $220 From $273, Maintains Buy Rating - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 06, 2026

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Omnicell (OMCL) and MiMedx Group (MDXG) - The Globe and Mail

Feb 06, 2026
pulisher
Feb 06, 2026

IQVIA Slipped 1% on AI Pivot: Why the Stock Could Rebound to $303 in 2026? - TIKR.com

Feb 06, 2026
pulisher
Feb 06, 2026

Research Alert: CFRA Maintains Buy Rating On Shares Of Iqvia Holdings Inc. - 富途牛牛

Feb 06, 2026
pulisher
Feb 05, 2026

IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com Nigeria

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA (IQV) Stock Trades Down, Here Is Why - Finviz

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA Holdings (IQV) Q4 2025 Earnings Call Transcript - Fortune

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Stron - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA Stock Drops as 2026 Outlook Misses Wall Street Expectations - Blockonomi

Feb 05, 2026
pulisher
Feb 05, 2026

IQVIA backs AI strategy as analysts question impact on business - marketscreener.com

Feb 05, 2026

Iqvia Holdings Inc Stock (IQV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$207.84
price down icon 2.18%
diagnostics_research MTD
$1,357.92
price down icon 2.49%
diagnostics_research WAT
$319.83
price down icon 2.85%
diagnostics_research LH
$278.11
price down icon 4.06%
diagnostics_research DGX
$206.86
price down icon 1.18%
Cap:     |  Volume (24h):